Reverse Transcriptase-polymerase Chain Reaction
Reverse Transcriptase-polymerase chain reaction (RT-PCR) is a laboratory technique used in the detection of viral RNA, including the RNA of coronaviruses. RT-PCR techniques have been widely used in the diagnosis of COVID-19 since its outbreak. The process involves the conversion of RNA into a complementary DNA (cDNA) sequence using reverse transcription enzyme, reverse transcriptase, followed by amplification of this cDNA using polymerase chain reaction (PCR). The amplified signal is then detected using fluorescence-based assays. RT-PCR is considered sensitive and specific for the detection of viral RNA. However, false-negative results may occur if the virus concentration is too low, or if there is an error in the sampling or testing process. Therefore, proper sample collection, preservation, and handling are crucial. Several RT-PCR assays have been designed and approved by regulatory authorities for COVID-19 diagnosis globally. These assays have been continually updated to increase their sensitivity and specificity, including the development of multiplex assays that can detect not only SARS-CoV-2 but also other respiratory viral infections. In conclusion, RT-PCR is a powerful diagnostic tool for viral RNA detection, including COVID-19. Its accuracy and sensitivity, along with advancements in technique, make it a critical component in the diagnosis and management of the pandemic.
←